{"id":"https://openalex.org/W4386910972","doi":"https://doi.org/10.1038/s41416-023-02431-7","title":"A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer","display_name":"A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer","publication_year":2023,"publication_date":"2023-09-20","ids":{"openalex":"https://openalex.org/W4386910972","doi":"https://doi.org/10.1038/s41416-023-02431-7","pmid":"https://pubmed.ncbi.nlm.nih.gov/37731023","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10646086"},"language":"en","primary_location":{"id":"doi:10.1038/s41416-023-02431-7","doi":"https://doi.org/10.1038/s41416-023-02431-7","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41416-023-02431-7","pdf_url":"https://www.nature.com/articles/s41416-023-02431-7.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/s41416-023-02431-7.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066673450","display_name":"Daphne Day","orcid":"https://orcid.org/0000-0001-8262-2441","observed_orcids":["https://orcid.org/0000-0001-8262-2441"]},"institutions":[{"id":"https://openalex.org/I2801350665","display_name":"Monash Medical Centre","ror":"https://ror.org/036s9kg65","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801350665","https://openalex.org/I4210121067"]},{"id":"https://openalex.org/I4210121067","display_name":"Monash Health","ror":"https://ror.org/02t1bej08","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210121067"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Daphne Day","raw_affiliation_strings":["Department of Medical Oncology, Monash Health, Clayton, VIC, Australia. Daphne.Day@monash.edu","Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia. Daphne.Day@monash.edu","Department of Medical Oncology, Monash Health, Clayton, Australia","Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia"],"raw_orcid":"https://orcid.org/0000-0001-8262-2441","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Monash Health, Clayton, VIC, Australia. Daphne.Day@monash.edu","institution_ids":["https://openalex.org/I2801350665","https://openalex.org/I4210121067"]},{"raw_affiliation_string":"Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia. Daphne.Day@monash.edu","institution_ids":["https://openalex.org/I56590836"]},{"raw_affiliation_string":"Department of Medical Oncology, Monash Health, Clayton, Australia","institution_ids":["https://openalex.org/I4210121067"]},{"raw_affiliation_string":"Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia","institution_ids":["https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034431014","display_name":"John Park","orcid":"https://orcid.org/0000-0001-9290-8179","observed_orcids":["https://orcid.org/0000-0001-9290-8179"]},"institutions":[{"id":"https://openalex.org/I99043593","display_name":"Macquarie University","ror":"https://ror.org/01sf06y89","country_code":"AU","type":"education","lineage":["https://openalex.org/I99043593"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"John J. Park","raw_affiliation_strings":["Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, NSW, Australia","Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, NSW, Australia","institution_ids":["https://openalex.org/I99043593"]},{"raw_affiliation_string":"Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, Australia","institution_ids":["https://openalex.org/I99043593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053835464","display_name":"Jermaine Ian George Coward","orcid":"https://orcid.org/0000-0002-2309-9379","observed_orcids":["https://orcid.org/0000-0002-2309-9379"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4210167184","display_name":"Icon (Australia)","ror":"https://ror.org/05nh0hr31","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210167184"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Jermaine Coward","raw_affiliation_strings":["Faculty of Medicine, University of Queensland, Herston, QLD, Australia","Medical Oncology, Icon Cancer Care - South Brisbane, South Brisbane, QLD, Australia","Faculty of Medicine, University of Queensland, Herston, Australia","Medical Oncology, Icon Cancer Care - South Brisbane, South Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, University of Queensland, Herston, QLD, Australia","institution_ids":["https://openalex.org/I165143802"]},{"raw_affiliation_string":"Medical Oncology, Icon Cancer Care - South Brisbane, South Brisbane, QLD, Australia","institution_ids":["https://openalex.org/I4210167184"]},{"raw_affiliation_string":"Faculty of Medicine, University of Queensland, Herston, Australia","institution_ids":["https://openalex.org/I165143802"]},{"raw_affiliation_string":"Medical Oncology, Icon Cancer Care - South Brisbane, South Brisbane, Australia","institution_ids":["https://openalex.org/I4210167184"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024968173","display_name":"Ben Markman","orcid":"https://orcid.org/0000-0002-0080-2842","observed_orcids":["https://orcid.org/0000-0002-0080-2842"]},"institutions":[{"id":"https://openalex.org/I4210121067","display_name":"Monash Health","ror":"https://ror.org/02t1bej08","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210121067"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Ben Markman","raw_affiliation_strings":["Department of Medical Oncology, Monash Health, Clayton, VIC, Australia","Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia","Department of Medical Oncology, Monash Health, Clayton, Australia","Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Monash Health, Clayton, VIC, Australia","institution_ids":["https://openalex.org/I4210121067"]},{"raw_affiliation_string":"Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia","institution_ids":["https://openalex.org/I56590836"]},{"raw_affiliation_string":"Department of Medical Oncology, Monash Health, Clayton, Australia","institution_ids":["https://openalex.org/I4210121067"]},{"raw_affiliation_string":"Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia","institution_ids":["https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027672041","display_name":"Charlotte Lemech","orcid":"https://orcid.org/0000-0002-5399-9431","observed_orcids":["https://orcid.org/0000-0002-5399-9431"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Charlotte Lemech","raw_affiliation_strings":["Drug Development, Scientia Clinical Research, Randwick, NSW, Australia","School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia","Drug Development, Scientia Clinical Research, Randwick, Australia","School of Clinical Medicine, University of New South Wales, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development, Scientia Clinical Research, Randwick, NSW, Australia","institution_ids":[]},{"raw_affiliation_string":"School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I31746571"]},{"raw_affiliation_string":"Drug Development, Scientia Clinical Research, Randwick, Australia","institution_ids":[]},{"raw_affiliation_string":"School of Clinical Medicine, University of New South Wales, Sydney, Australia","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033534440","display_name":"James Chun-Yen Kuo","orcid":"https://orcid.org/0000-0001-7123-8591","observed_orcids":["https://orcid.org/0000-0001-7123-8591"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"James C. Kuo","raw_affiliation_strings":["Drug Development, Scientia Clinical Research, Randwick, NSW, Australia","School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia","Drug Development, Scientia Clinical Research, Randwick, Australia","School of Clinical Medicine, University of New South Wales, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development, Scientia Clinical Research, Randwick, NSW, Australia","institution_ids":[]},{"raw_affiliation_string":"School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I31746571"]},{"raw_affiliation_string":"Drug Development, Scientia Clinical Research, Randwick, Australia","institution_ids":[]},{"raw_affiliation_string":"School of Clinical Medicine, University of New South Wales, Sydney, Australia","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050622730","display_name":"Amy Prawira","orcid":"https://orcid.org/0000-0003-2640-9333","observed_orcids":["https://orcid.org/0000-0003-2640-9333"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]},{"id":"https://openalex.org/I4210087284","display_name":"St Vincent's Hospital Sydney","ror":"https://ror.org/000ed3w25","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210087284"]},{"id":"https://openalex.org/I4210153363","display_name":"The Kinghorn Cancer Centre","ror":"https://ror.org/04fw0fr46","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210153363"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Amy Prawira","raw_affiliation_strings":["Department of Medical Oncology, The Kinghorn Cancer Centre, St. Vincent's Hospital Sydney, Darlinghurst, NSW, Australia","School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia","Department of Medical Oncology, The Kinghorn Cancer Centre, St. Vincent\u2019s Hospital Sydney, Darlinghurst, Australia","School of Clinical Medicine, University of New South Wales, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The Kinghorn Cancer Centre, St. Vincent's Hospital Sydney, Darlinghurst, NSW, Australia","institution_ids":["https://openalex.org/I4210087284","https://openalex.org/I4210153363"]},{"raw_affiliation_string":"School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I31746571"]},{"raw_affiliation_string":"Department of Medical Oncology, The Kinghorn Cancer Centre, St. Vincent\u2019s Hospital Sydney, Darlinghurst, Australia","institution_ids":["https://openalex.org/I4210087284","https://openalex.org/I4210153363"]},{"raw_affiliation_string":"School of Clinical Medicine, University of New South Wales, Sydney, Australia","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021075431","display_name":"Michael Paul Brown","orcid":"https://orcid.org/0000-0002-5796-1932","observed_orcids":["https://orcid.org/0000-0002-5796-1932","https://orcid.org/0000-0002-0495-7315"]},"institutions":[{"id":"https://openalex.org/I1320133117","display_name":"Royal Adelaide Hospital","ror":"https://ror.org/00carf720","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1320133117","https://openalex.org/I4392738059"]},{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Michael P. Brown","raw_affiliation_strings":["Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, SA, Australia","School of Medicine, University of Adelaide, Adelaide, SA, Australia","Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, Australia","School of Medicine, University of Adelaide, Adelaide, Australia"],"raw_orcid":"https://orcid.org/0000-0002-5796-1932","affiliations":[{"raw_affiliation_string":"Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, SA, Australia","institution_ids":["https://openalex.org/I1320133117"]},{"raw_affiliation_string":"School of Medicine, University of Adelaide, Adelaide, SA, Australia","institution_ids":["https://openalex.org/I5681781"]},{"raw_affiliation_string":"Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, Australia","institution_ids":["https://openalex.org/I1320133117"]},{"raw_affiliation_string":"School of Medicine, University of Adelaide, Adelaide, Australia","institution_ids":["https://openalex.org/I5681781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021505713","display_name":"Sarwan K. Bishnoi","orcid":"https://orcid.org/0009-0006-5841-0602","observed_orcids":["https://orcid.org/0009-0006-5841-0602"]},"institutions":[{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Sarwan Bishnoi","raw_affiliation_strings":["Medical Oncology, Ashford Cancer Centre Research and ICON Cancer Centre, Kurralta Park and Division of Medicine, University of Adelaide, Adelaide, SA, Australia","Medical Oncology, Ashford Cancer Centre Research and ICON Cancer Centre, Kurralta Park and Division of Medicine, University of Adelaide, Adelaide, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Ashford Cancer Centre Research and ICON Cancer Centre, Kurralta Park and Division of Medicine, University of Adelaide, Adelaide, SA, Australia","institution_ids":["https://openalex.org/I5681781"]},{"raw_affiliation_string":"Medical Oncology, Ashford Cancer Centre Research and ICON Cancer Centre, Kurralta Park and Division of Medicine, University of Adelaide, Adelaide, Australia","institution_ids":["https://openalex.org/I5681781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052972588","display_name":"Dusan Kotasek","orcid":"https://orcid.org/0000-0002-2170-3560","observed_orcids":["https://orcid.org/0000-0002-2170-3560"]},"institutions":[{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Dusan Kotasek","raw_affiliation_strings":["Medical Oncology, Ashford Cancer Centre Research and ICON Cancer Centre, Kurralta Park and Division of Medicine, University of Adelaide, Adelaide, SA, Australia","Medical Oncology, Ashford Cancer Centre Research and ICON Cancer Centre, Kurralta Park and Division of Medicine, University of Adelaide, Adelaide, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Ashford Cancer Centre Research and ICON Cancer Centre, Kurralta Park and Division of Medicine, University of Adelaide, Adelaide, SA, Australia","institution_ids":["https://openalex.org/I5681781"]},{"raw_affiliation_string":"Medical Oncology, Ashford Cancer Centre Research and ICON Cancer Centre, Kurralta Park and Division of Medicine, University of Adelaide, Adelaide, Australia","institution_ids":["https://openalex.org/I5681781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114376803","display_name":"Robert Matthew Strother","orcid":"https://orcid.org/0000-0001-8118-8954","observed_orcids":["https://orcid.org/0000-0001-8118-8954"]},"institutions":[{"id":"https://openalex.org/I2802773633","display_name":"Christchurch Hospital","ror":"https://ror.org/003nvpm64","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I2802773633","https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"R. Matthew Strother","raw_affiliation_strings":["Medical Oncology, Christchurch Hospital, Christchurch, Canterbury, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Christchurch Hospital, Christchurch, Canterbury, New Zealand","institution_ids":["https://openalex.org/I2802773633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034270737","display_name":"Rasha Cosman","orcid":"https://orcid.org/0000-0002-4746-0747","observed_orcids":["https://orcid.org/0000-0002-4746-0747"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]},{"id":"https://openalex.org/I4210087284","display_name":"St Vincent's Hospital Sydney","ror":"https://ror.org/000ed3w25","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210087284"]},{"id":"https://openalex.org/I4210153363","display_name":"The Kinghorn Cancer Centre","ror":"https://ror.org/04fw0fr46","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210153363"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Rasha Cosman","raw_affiliation_strings":["Department of Medical Oncology, The Kinghorn Cancer Centre, St. Vincent's Hospital Sydney, Darlinghurst, NSW, Australia","School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia","Department of Medical Oncology, The Kinghorn Cancer Centre, St. Vincent\u2019s Hospital Sydney, Darlinghurst, Australia","School of Clinical Medicine, University of New South Wales, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The Kinghorn Cancer Centre, St. Vincent's Hospital Sydney, Darlinghurst, NSW, Australia","institution_ids":["https://openalex.org/I4210087284","https://openalex.org/I4210153363"]},{"raw_affiliation_string":"School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I31746571"]},{"raw_affiliation_string":"Department of Medical Oncology, The Kinghorn Cancer Centre, St. Vincent\u2019s Hospital Sydney, Darlinghurst, Australia","institution_ids":["https://openalex.org/I4210087284","https://openalex.org/I4210153363"]},{"raw_affiliation_string":"School of Clinical Medicine, University of New South Wales, Sydney, Australia","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085354851","display_name":"Rila Su","orcid":"https://orcid.org/0000-0002-0299-4390","observed_orcids":["https://orcid.org/0000-0002-0299-4390"]},"institutions":[{"id":"https://openalex.org/I4405267831","display_name":"CStone Pharmaceuticals (China)","ror":"https://ror.org/04m2ekz50","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267831"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Rila Su","raw_affiliation_strings":["Translational Medicine and Early Development, CStone Pharmaceuticals (Suzhou) Co., Ltd., Suzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine and Early Development, CStone Pharmaceuticals (Suzhou) Co., Ltd., Suzhou, China","institution_ids":["https://openalex.org/I4405267831"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101824667","display_name":"Yiding Ma","orcid":"https://orcid.org/0000-0002-6939-0794","observed_orcids":["https://orcid.org/0000-0002-6939-0794"]},"institutions":[{"id":"https://openalex.org/I4405267831","display_name":"CStone Pharmaceuticals (China)","ror":"https://ror.org/04m2ekz50","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267831"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yiding Ma","raw_affiliation_strings":["Clinical Department, CStone Pharmaceuticals (Suzhou) Co., Ltd., Suzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Department, CStone Pharmaceuticals (Suzhou) Co., Ltd., Suzhou, China","institution_ids":["https://openalex.org/I4405267831"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101262680","display_name":"Zenglian Yue","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267831","display_name":"CStone Pharmaceuticals (China)","ror":"https://ror.org/04m2ekz50","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267831"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zenglian Yue","raw_affiliation_strings":["Translational Medicine and Early Development, CStone Pharmaceuticals (Suzhou) Co., Ltd., Suzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine and Early Development, CStone Pharmaceuticals (Suzhou) Co., Ltd., Suzhou, China","institution_ids":["https://openalex.org/I4405267831"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904809","display_name":"Hui-Han Hu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267831","display_name":"CStone Pharmaceuticals (China)","ror":"https://ror.org/04m2ekz50","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267831"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hui-han Hu","raw_affiliation_strings":["Translational Medicine and Early Development, CStone Pharmaceuticals (Suzhou) Co., Ltd., Suzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine and Early Development, CStone Pharmaceuticals (Suzhou) Co., Ltd., Suzhou, China","institution_ids":["https://openalex.org/I4405267831"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rachel Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267831","display_name":"CStone Pharmaceuticals (China)","ror":"https://ror.org/04m2ekz50","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267831"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Rachel Wu","raw_affiliation_strings":["Clinical Department, CStone Pharmaceuticals (Suzhou) Co., Ltd., Suzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Department, CStone Pharmaceuticals (Suzhou) Co., Ltd., Suzhou, China","institution_ids":["https://openalex.org/I4405267831"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005073161","display_name":"Peiqi Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267831","display_name":"CStone Pharmaceuticals (China)","ror":"https://ror.org/04m2ekz50","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267831"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Peiqi Li","raw_affiliation_strings":["Translational Medicine and Early Development, CStone Pharmaceuticals (Suzhou) Co., Ltd., Suzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine and Early Development, CStone Pharmaceuticals (Suzhou) Co., Ltd., Suzhou, China","institution_ids":["https://openalex.org/I4405267831"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5114045976","display_name":"Archie N. Tse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267831","display_name":"CStone Pharmaceuticals (China)","ror":"https://ror.org/04m2ekz50","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267831"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Archie N. Tse","raw_affiliation_strings":["Translational Medicine and Early Development, CStone Pharmaceuticals (Suzhou) Co., Ltd., Suzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine and Early Development, CStone Pharmaceuticals (Suzhou) Co., Ltd., Suzhou, China","institution_ids":["https://openalex.org/I4405267831"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":13,"corresponding_author_ids":["https://openalex.org/A5066673450"],"corresponding_institution_ids":["https://openalex.org/I2801350665","https://openalex.org/I4210121067","https://openalex.org/I56590836"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":{"value":4690,"currency":"USD","value_usd":4690},"fwci":0.9713,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.75761651,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":98},"biblio":{"volume":"129","issue":"10","first_page":"1608","last_page":"1618"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9071999788284302,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9071999788284302,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.08959999680519104,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.9750000238418579},{"id":"https://openalex.org/keywords/regorafenib","display_name":"regorafenib","score":0.9649999737739563},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8460000157356262},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6759999990463257},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7390000224113464},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8669999837875366},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.6880000233650208},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.7590000033378601}],"concepts":[{"id":"https://openalex.org/C2776248978","wikidata":"https://www.wikidata.org/wiki/Q3891664","display_name":"Regorafenib","level":4,"score":0.9490466713905334},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8238674998283386},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6260837316513062},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.6210705637931824},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6137100458145142},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5095469951629639},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49033379554748535},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4361013174057007},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3824407458305359},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.35292232036590576}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012004","descriptor_name":"Rectal Neoplasms","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1038/s41416-023-02431-7","doi":"https://doi.org/10.1038/s41416-023-02431-7","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41416-023-02431-7","pdf_url":"https://www.nature.com/articles/s41416-023-02431-7.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10646086","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10646086","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10646086/pdf/41416_2023_Article_2431.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmid:37731023","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37731023","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1038/s41416-023-02431-7","doi":"https://doi.org/10.1038/s41416-023-02431-7","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41416-023-02431-7","pdf_url":"https://www.nature.com/articles/s41416-023-02431-7.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4386910972.pdf","grobid_xml":"https://content.openalex.org/works/W4386910972.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W2016983859","https://openalex.org/W2111851685","https://openalex.org/W2147834058","https://openalex.org/W2152897456","https://openalex.org/W2160834915","https://openalex.org/W2222086386","https://openalex.org/W2254907138","https://openalex.org/W2345415641","https://openalex.org/W2509486054","https://openalex.org/W2527905628","https://openalex.org/W2560367415","https://openalex.org/W2560827811","https://openalex.org/W2606367731","https://openalex.org/W2607272476","https://openalex.org/W2615964575","https://openalex.org/W2739132742","https://openalex.org/W2763679284","https://openalex.org/W2923110622","https://openalex.org/W2938357216","https://openalex.org/W2940759533","https://openalex.org/W2969365220","https://openalex.org/W2981790403","https://openalex.org/W3020689019","https://openalex.org/W3029868931","https://openalex.org/W3088397061","https://openalex.org/W3108723718","https://openalex.org/W3110528877","https://openalex.org/W3119086885","https://openalex.org/W3122024015","https://openalex.org/W3139884936","https://openalex.org/W3168643875","https://openalex.org/W3203867941","https://openalex.org/W3207665479","https://openalex.org/W4200613855","https://openalex.org/W4206185909","https://openalex.org/W4229029683","https://openalex.org/W4281630256","https://openalex.org/W4281788768","https://openalex.org/W4293331374"],"related_works":["https://openalex.org/W4402217003","https://openalex.org/W2947441361","https://openalex.org/W2969718979","https://openalex.org/W4392160227","https://openalex.org/W2938383858","https://openalex.org/W3031092810","https://openalex.org/W3088542838","https://openalex.org/W4229029683","https://openalex.org/W2012708129","https://openalex.org/W2328819506"],"abstract_inverted_index":{"BACKGROUND:":[0],"We":[1],"assessed":[2],"nofazinlimab,":[3],"an":[4],"anti-PD-1":[5],"antibody,":[6],"in":[7,14,123,143,156,181,200],"solid":[8],"tumors":[9],"and":[10,30,34,59,95,127,134,137,139,141,147,154,159,176],"combined":[11,48],"with":[12,49,78,197],"regorafenib":[13,35],"metastatic":[15],"colorectal":[16],"cancer":[17],"(mCRC).":[18],"METHODS:":[19],"This":[20],"phase":[21,63,88],"1":[22,73],"study":[23],"comprised":[24],"nofazinlimab":[25,51,187],"dose":[26,36],"escalation":[27,37],"(phase":[28,32],"1a)":[29],"expansion":[31],"1b),":[33],"(80":[38],"or":[39],"120":[40],"mg":[41,80],"QD,":[42],"days":[43],"1-21":[44],"of":[45],"28-day":[46],"cycles)":[47],"300-mg":[50],"Q4W":[52],"(part":[53],"2a)":[54],"to":[55,74],"determine":[56],"safety,":[57],"efficacy,":[58],"RP2D.":[60,86],"RESULTS:":[61],"In":[62,87,102,162],"1a":[64,158],"(N":[65,90,105],"=":[66,91,106],"21),":[67],"no":[68,165],"dose-limiting":[69],"toxicity":[70],"occurred":[71],"from":[72],"10":[75],"mg/kg":[76],"Q3W,":[77],"200":[79],"Q3W":[81,97],"determined":[82],"as":[83],"the":[84,116],"monotherapy":[85,172],"1b":[89],"87),":[92],"400-mg":[93],"Q6W":[94],"200-mg":[96],"regimens":[98,109],"were":[99,110,132,152],"found":[100],"comparable.":[101],"part":[103,148,163],"2a":[104],"14),":[107],"both":[108],"deemed":[111],"plausible":[112],"RP2Ds.":[113],"Fatigue":[114],"was":[115,173,194],"most":[117],"frequent":[118],"treatment-emergent":[119],"adverse":[120],"event":[121],"(AE)":[122],"this":[124],"study.":[125],"Any-grade":[126],"grade":[128],"3/4":[129],"nofazinlimab-related":[130],"AEs":[131],"71.4%":[133],"14.3%,":[135],"56.3%":[136],"5.7%,":[138],"57.1%":[140],"21.4%":[142],"phases":[144,157],"1a,":[145],"1b,":[146,160],"2a,":[149,164],"respectively.":[150,161],"ORRs":[151],"14.3%":[153],"25.3%":[155],"patients":[166],"had":[167,188],"radiological":[168],"responses.":[169],"CONCLUSIONS:":[170],"Nofazinlimab":[171],"well":[174],"tolerated":[175],"demonstrated":[177],"preliminary":[178],"anti-tumor":[179],"activity":[180],"multiple":[182],"tumor":[183],"types.":[184],"Regorafenib":[185],"plus":[186],"a":[189],"manageable":[190],"safety":[191],"profile":[192],"but":[193],"not":[195],"associated":[196],"any":[198],"response":[199],"mCRC.":[201],"CLINICAL":[202],"TRIAL":[203],"REGISTR":[204],"ATION:":[205],"Clinicaltrials.gov":[206],"(NCT03475251).":[207]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-09-22T00:00:00"}